Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial
新辅助乐伐替尼联合帕博利珠单抗治疗默克尔细胞癌:一项研究者发起的开放标签II期试验
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013939
Brohl, Andrew S; Sondak, Vernon K; Wuthrick, Evan J; Kim, Younchul; Eroglu, Zeynep; Markowitz, Joseph; Tarhini, Ahmad A; Fan, Wenyi; Martin, Justin; Sneed, Lymon; Perez, Matthew C; Sarnaik, Amod; Harrington, Michael; Neves, Rogerio I; Gonzalez, Ricardo J; Cruse, C Wayne; Zager, Jonathan S; Tsai, Kenneth Y; Khushalani, Nikhil I